Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (ACT1VATE) is testing an intervention to address emotional distress to improve outcomes in diverse adults with Type 1 diabetes; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Scripps Whittier Diabetes Institute | Conditions: Type 1 Diabetes | Phase 2 | Status: RECRUITING